SCHEMBL16112488

SCHEMBL16112488

CC1CN(C(=O)O)CC(C)N1c1ccc(-c2cnc3c(Br)cnn3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB1 Q9Y478 3/20 0.53
PRKAB2 O43741 2/20 0.53
PRKAG1 P54619 2/20 0.53
PRKAA2 P54646 2/20 0.53
PRKAA1 Q13131 2/20 0.53
PRKAG3 Q9UGI9 2/20 0.53
PRKAG2 Q9UGJ0 2/20 0.53
KDR P35968 2/20 0.50
PLK4 O00444 1/20 0.50
AURKA O14965 1/20 0.50
DYRK3 O43781 1/20 0.50
MAP4K4 O95819 1/20 0.50
NTRK1 P04629 1/20 0.50
INSR P06213 1/20 0.50
CDK1 P06493 1/20 0.50
FGFR1 P11362 1/20 0.50
FLT1 P17948 1/20 0.50
CDK2 P24941 1/20 0.50
MARK3 P27448 1/20 0.50
FLT4 P35916 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112700 0.88 PRKAB2 (0.49) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16112341 0.86 PLK4 (0.47) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL19611368 0.86 PLK4 (0.47) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16112343 0.86 PLK4 (0.47) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL19611367 0.86 PLK4 (0.47) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16112600 0.83 PLK4 (0.47) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL17531648 0.82 PRKAB1 (0.56) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16111465 0.76 PRKAB1 (0.52) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16111471 0.75 RET (0.52) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL16111470 0.75 RET (0.52) PRKAB1PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970311-A2 BMP INHIBITORS AND METHODS OF USE THEREOF The Brigham and Women's Hospital, Inc. (US) 2016-01-20 EP disclosed
WO-2014160203-A2 BMP INHIBITORS AND METHODS OF USE THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2014-10-02 WO disclosed